NCT07441291 2026-02-27
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Peking University People's Hospital
Phase 3 Recruiting
Clinical Trials
9 trialsNCT05929222 2025-12-24
FIL_GAZEBO
Fondazione Italiana Linfomi - ETS
Phase 3 Recruiting
NCT05232916 2025-10-03
FLAMINGO-01
Greenwich LifeSciences, Inc.
Phase 3 Recruiting
NCT05534087 2024-11-29
CLAUDIA
Seoul National University Hospital
Phase 3 Recruiting
NCT06323148 2024-03-21
Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)
Fudan University
Phase 3 Not yet recruiting
NCT03512197 2023-08-21
A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
Novartis
Phase 3 Completed
NCT04375683 2022-03-24
Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL
Zhongda Hospital
Phase 3 Unknown
NCT02724163 2021-10-08
Myechild01
University of Birmingham
Phase 3 Recruiting
NCT00816049 2017-04-21
ALL2008con
Rigshospitalet, Denmark
Phase 3 Completed